Maker LogoMake a Quiz [Free]Copy & Edit
Quiz MakerQuizzesGuides and HelpContactPrivacy & Security

Molecular Pathology and Targeted Therapy Quiz

In recurrent ovarian cancer, which factor best identifies patients who could benefit from PARP inhibitors?
HRD status
Response to platinum-based therapy
Previous Platinum-free interval
For First line therapy of High grade serous ovarian cancer with PARP inhibitors, what percentage of patients have HRD in the tumour?
15%
25%
50%
Which is the molecular type of endometrial carcinoma, most likely associated with good prognosis?
P53 abnormal
Non specific molecular profile
Mismatch Repair Deficient
Pole mutated
{"name":"Molecular Pathology and Targeted Therapy Quiz", "url":"https://www.quiz-maker.com/QPREVIEW","txt":"In recurrent ovarian cancer, which factor best identifies patients who could benefit from PARP inhibitors?, For First line therapy of High grade serous ovarian cancer with PARP inhibitors, what percentage of patients have HRD in the tumour?, Please enter your email address","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}

More Quizzes

Explora il Tuo Futuro Medico
158116
Serie A 2019/20 Season Quiz
158196
Find you PCOS Type
136102
Magical Houses and Spells Quiz
10590
Kin Time
15853
AIS AML-CTF Training Quiz
14792
COVID- 19
15894
Who out of da mains are u?
15845
Which friend are you?
15871
Tense
15870
Descubra sua Profissão Ideal!
147162
Descubre el Common Law
158291
Quiz Maker Logo Make your own Quiz
Powered by: Quiz Maker